Epidemiology and profile of pediatric burns in a large referral center

Ami Shah1, Srinivasan Suresh, Ronald Thomas

  • 1Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Clinical Pediatrics
|April 29, 2011
PubMed

Insights

Analyzing pediatric burn injury patterns reveals that scalds are the most common cause. Understanding these patterns can inform targeted prevention strategies to reduce childhood burn hospitalizations.

Area of Science:

  • Pediatric injury prevention
  • Burn epidemiology
  • Public health

Background:

  • Pediatric burns represent a significant public health concern, leading to over 100,000 hospitalizations annually.
  • Burns are largely preventable injuries in children.
  • Identifying specific injury patterns is crucial for developing effective prevention strategies.

Purpose of the Study:

  • To analyze pediatric burn injury patterns.
  • To identify age-specific and injury-specific risk factors.
  • To inform the development of targeted prevention strategies.

Main Methods:

  • Utilized a 9-year dataset from a burn registry.
  • Employed cross-tabulations to assess associations between variables.
  • Applied analysis of variance (ANOVA) to compare injury patterns.

Main Results:

  • Children under 1 year old constituted 16% of burn admissions.
  • Scalds were the predominant injury mechanism (48.4%).
  • Electrical and chemical burns were more frequent in older children; suspected abuse accounted for 6.7% of admissions, and house fires resulted in larger burn surface areas.

Conclusions:

  • Burn injury patterns provide valuable predictors for public health interventions.
  • Targeted public health initiatives based on these predictors can potentially decrease burn injury incidence.
  • Data-driven strategies are essential for reducing pediatric burn hospitalizations.
Abstract

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...